- Home
- PAYS vs ORGO Comparison
PAYS vs ORGO Comparison
Compare PAYS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYS | ORGO |
|---|---|---|
| Founded | 2001 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 348.6M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PAYS | ORGO |
|---|---|---|
| Price | $5.76 | $2.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $9.42 | $8.50 |
| AVG Volume (30 Days) | ★ 1.0M | 659.4K |
| Earning Date | 03-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 85.71 | ★ 1600.00 |
| EPS | 0.13 | ★ 0.15 |
| Revenue | $24,120,434.00 | ★ $564,169,000.00 |
| Revenue This Year | $21.22 | N/A |
| Revenue Next Year | $14.67 | $26.27 |
| P/E Ratio | $43.23 | ★ $15.27 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $1.80 | $2.28 |
| 52 Week High | $8.88 | $7.08 |
Technical Indicators
Market Signals| Indicator | PAYS | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 81.90 | 22.28 |
| Support Level | $5.09 | N/A |
| Resistance Level | $5.83 | $4.12 |
| Average True Range (ATR) | 0.34 | 0.11 |
| MACD | 0.29 | 0.02 |
| Stochastic Oscillator | 88.99 | 7.14 |
Price Performance
Historical ComparisonAbout PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.